118 related articles for article (PubMed ID: 31499390)
1. Female mice are protected against acute olanzapine-induced hyperglycemia.
Medak KD; Townsend LK; Hahn MK; Wright DC
Psychoneuroendocrinology; 2019 Dec; 110():104413. PubMed ID: 31499390
[TBL] [Abstract][Full Text] [Related]
2. Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia.
Castellani LN; Peppler WT; Sutton CD; Whitfield J; Charron MJ; Wright DC
Psychoneuroendocrinology; 2017 Aug; 82():38-45. PubMed ID: 28500893
[TBL] [Abstract][Full Text] [Related]
3. GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia.
Medak KD; Shamshoum H; Peppler WT; Wright DC
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1101-E1111. PubMed ID: 33017220
[TBL] [Abstract][Full Text] [Related]
4. Voluntary physical activity protects against olanzapine-induced hyperglycemia.
Shamshoum H; McKie GL; Medak KD; Ashworth KE; Kemp BE; Wright DC
J Appl Physiol (1985); 2021 Feb; 130(2):466-478. PubMed ID: 33382959
[TBL] [Abstract][Full Text] [Related]
5. AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis.
Bush ND; Townsend LK; Wright DC
J Pharmacol Exp Ther; 2018 Jun; 365(3):526-535. PubMed ID: 29581153
[TBL] [Abstract][Full Text] [Related]
6. AMPK β1 activation suppresses antipsychotic-induced hyperglycemia in mice.
Shamshoum H; Medak KD; Townsend LK; Ashworth KE; Bush ND; Halm MK; Kemp BE; Wright DC
FASEB J; 2019 Dec; 33(12):14010-14021. PubMed ID: 31581839
[TBL] [Abstract][Full Text] [Related]
7. Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice.
Castellani LN; Peppler WT; Miotto PM; Bush N; Wright DC
Sci Rep; 2018 Jan; 8(1):772. PubMed ID: 29335597
[TBL] [Abstract][Full Text] [Related]
8. Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism.
Medak KD; Weber AJ; Shamshoum H; McKie GL; Hahn MK; Wright DC
Front Pharmacol; 2023; 14():1127634. PubMed ID: 36937886
[TBL] [Abstract][Full Text] [Related]
9. Obesity exacerbates the acute metabolic side effects of olanzapine.
Townsend LK; Peppler WT; Bush ND; Wright DC
Psychoneuroendocrinology; 2018 Feb; 88():121-128. PubMed ID: 29241148
[TBL] [Abstract][Full Text] [Related]
10. Fasting or the short-term consumption of a ketogenic diet protects against antipsychotic-induced hyperglycaemia in mice.
Shamshoum H; Medak KD; McKie GL; Hahn MK; Wright DC
J Physiol; 2022 Jun; 600(11):2713-2728. PubMed ID: 35507699
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
Ballon JS; Pajvani UB; Mayer LE; Freyberg Z; Freyberg R; Contreras I; Rosenbaum M; Leibel RL; Lieberman JA
J Psychopharmacol; 2018 May; 32(5):533-540. PubMed ID: 29444618
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
Smith GC; Vickers MH; Shepherd PR
Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
[TBL] [Abstract][Full Text] [Related]
13. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
[TBL] [Abstract][Full Text] [Related]
14. Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine.
Medak KD; Jeromson S; Bellucci A; Arbeau M; Wright DC
iScience; 2024 Jan; 27(1):108628. PubMed ID: 38188526
[TBL] [Abstract][Full Text] [Related]
15. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
[TBL] [Abstract][Full Text] [Related]
16. Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance.
Girault EM; Alkemade A; Foppen E; Ackermans MT; Fliers E; Kalsbeek A
PLoS One; 2012; 7(8):e43244. PubMed ID: 22905238
[TBL] [Abstract][Full Text] [Related]
17. Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine.
Nagata M; Nakajima M; Ishiwata Y; Takahashi Y; Takahashi H; Negishi K; Yasuhara M
Biol Pharm Bull; 2016; 39(5):754-61. PubMed ID: 27150145
[TBL] [Abstract][Full Text] [Related]
18. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.
Yasui-Furukori N; Sato Y; Furukori H; Saito M; Nakagami T; Kaneko S
J Clin Psychiatry; 2009 Jan; 70(1):95-100. PubMed ID: 19026267
[TBL] [Abstract][Full Text] [Related]
19. Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance.
Li H; Fang M; Xu M; Li S; Du J; Li W; Chen H
PLoS One; 2016; 11(12):e0167930. PubMed ID: 27973621
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapine.
Wu C; Yuen J; Boyda HN; Procyshyn RM; Wang CK; Asiri YI; Pang CC; Honer WG; Barr AM
PLoS One; 2014; 9(9):e107116. PubMed ID: 25254366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
